Gene · 3399
Papers2,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Interplay of Transcription and Genome Topology Programs T Cell Development and Differentiation. | J Immunol | 2022 | 36469845 | PubTator, text mining | PubMed |
| Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer. | Front Pharmacol | 2022 | 36467074 | PubTator, text mining | PubMed |
| Future perspective of stem cell-derived exosomes: Cell-free therapeutic strategies for retinal degeneration. | Front Bioeng Biotechnol | 2022 | 36452207 | PubTator, text mining | PubMed |
| Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation. | BMC Cancer | 2022 | 36443709 | PubTator, text mining | PubMed |
| Predicting the Engineering Properties of Rocks from Textural Characteristics Using Some Soft Computing Approaches. | Materials (Basel) | 2022 | 36431407 | PubTator, text mining | PubMed |
| Identification of Factors Driving Doxorubicin-Resistant Ewing Tumor Cells to Survival. | Cancers (Basel) | 2022 | 36428591 | PubTator, text mining | PubMed |
| ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and CDH1 suppression. | J Cell Mol Med | 2022 | 36420658 | PubTator, text mining | PubMed |
| Regenerative Medicine and Angiogenesis; Focused on Cardiovascular Disease. | Adv Pharm Bull | 2022 | 36415645 | PubTator, text mining | PubMed |
| Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies. | Biol Sex Differ | 2022 | 36414996 | PubTator, text mining | PubMed |
| Identification of key biomarkers in neonatal sepsis by integrated bioinformatics analysis and clinical validation. | Heliyon | 2022 | 36411922 | PubTator, text mining | PubMed |
| Exploiting the role of T cells in the pathogenesis of Sjögren's syndrome for therapeutic treatment. | Front Immunol | 2022 | 36389806 | PubTator, text mining | PubMed |
| EBV-associated diseases: Current therapeutics and emerging technologies. | Front Immunol | 2022 | 36389670 | PubTator, text mining | PubMed |
| Human T lymphocytes at tumor sites. | Semin Immunopathol | 2022 | 36385379 | PubTator, text mining | PubMed |
| The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance. | Int J Mol Sci | 2022 | 36362359 | PubTator, text mining | PubMed |
| Ameliorative Effect of Tocotrienols on Perimenopausal-Associated Osteoporosis-A Review. | Antioxidants (Basel) | 2022 | 36358550 | PubTator, text mining | PubMed |
| BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor CAR T cell stemness and exhaustion. | Sci Transl Med | 2022 | 36350986 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals different signatures of mesenchymal stromal cell pluripotent-like and multipotent populations. | iScience | 2022 | 36339265 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells. | Arch Toxicol | 2022 | 36326898 | PubTator, text mining | PubMed |
| speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing. | Nat Commun | 2022 | 36323661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3399/papers?page=26